Checkpoint inhibitors for the treatment of advanced hepatocellular carcinoma
Checkpoint inhibitors for the treatment of advanced hepatocellular carcinoma
COVID-19 and breast cancer: How should we treat our patients?
Comment: JAVELIN-100 for metastatic urothelial cancer
HCRN GU16-260: Nivolumab and salvage nivolumab ipilimumab in treatment-naïve patients with advanced renal cell carcinoma
Updated results from KEYNOTE-426 for metastatic kidney cancer
ASCO 2020: Breast cancer roundup
The PANDA study: Combining panitumumab with FOLFOX or 5FU in elderly patients with RAS-BRAF WT metastatic colorectal cancer
Perioperative novel systemic immunotherapy-based approaches in urinary cancers
ASCO 2020: Updates in renal cancer
TROPHIMMUN: Avelumab for gestational trophoblastic tumours resistant to monochemotherapy
KEYNOTE-177 results: Pembrolizumab versus chemotherapy for patients with MSI-H/dMMR colorectal cancer
Highlights from ASCO 2020